NEUCA S.A. (WSE:NEU)
694.00
+4.00 (0.58%)
Jun 4, 2025, 3:44 PM CET
NEUCA Revenue
NEUCA had revenue of 3.37B PLN in the quarter ending March 31, 2025, with 6.44% growth. This brings the company's revenue in the last twelve months to 12.82B, up 7.04% year-over-year. In the year 2024, NEUCA had annual revenue of 12.61B with 6.76% growth.
Revenue (ttm)
12.82B
Revenue Growth
+7.04%
P/S Ratio
0.24
Revenue / Employee
2.88M
Employees
4,445
Market Cap
3.09B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 12.61B | 799.12M | 6.76% |
Dec 31, 2023 | 11.81B | 580.45M | 5.17% |
Dec 31, 2022 | 11.23B | 1.37B | 13.87% |
Dec 31, 2021 | 9.86B | 619.37M | 6.70% |
Dec 31, 2020 | 9.24B | 972.52M | 11.76% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Synektik Spólka Akcyjna | 556.63M |
Voxel | 556.98M |
Celon Pharma | 215.11M |
Ryvu Therapeutics | 97.57M |
Selvita | 359.79M |
Centrum Medyczne ENEL-MED | 735.59M |
EMC Instytut Medyczny | 836.81M |
Mercator Medical | 555.74M |